Dividend Distribution - The company plans to distribute a cash dividend of 0.074 CNY per share, totaling 64,908,636.54 CNY (including tax), which represents 67.76% of the net profit attributable to shareholders for the fiscal year 2024[6]. - The total cash dividend for the fiscal year 2024 is projected to be 146,541,299.09 CNY, including interim dividends already distributed[6]. - The board of directors has approved the profit distribution plan during the 27th meeting of the 9th board session[6]. - The cash dividend per share for the fiscal year 2023 is adjusted to 0.09305 RMB (including tax), with a total profit distribution amounting to 82,112,087.42 RMB (including tax)[148]. - The cash dividend for the mid-term profit distribution in 2024 is set at 0.93 RMB per 10 shares (including tax), totaling 81,632,662.55 RMB (including tax), which represents 43.45% of the net profit attributable to shareholders for the first three quarters of 2024[149]. - The total cash dividend amount for the last three accounting years is 340,034,009.84 RMB, with an average net profit of 285,964,120.95 RMB, resulting in a cash dividend ratio of 118.91%[156]. - The company has authorized the board of directors to decide on the mid-term profit distribution plan during the annual general meeting held on June 26, 2024[149]. Financial Performance - The company's operating revenue for 2024 was CNY 35.43 billion, representing a 5.30% increase compared to CNY 33.65 billion in 2023[22]. - The net profit attributable to shareholders decreased by 20.53% to CNY 216.25 million in 2024 from CNY 272.12 million in 2023[22]. - The basic earnings per share for 2024 was CNY 0.25, down 19.35% from CNY 0.31 in 2023[23]. - The net cash flow from operating activities showed a significant decline, dropping to -CNY 211.63 million in 2024 from CNY 311.58 million in 2023, a decrease of 167.92%[22]. - The total assets increased by 9.76% to CNY 18.82 billion at the end of 2024, compared to CNY 17.14 billion at the end of 2023[22]. - The company reported a net asset return rate of 2.91% for 2024, down from 3.79% in 2023, a decrease of 0.88 percentage points[23]. - The operating cost for the same period was 33.75 billion RMB, which is an increase of 5.88% compared to 31.88 billion RMB in the previous year[52]. - The gross profit margin decreased by 0.53 percentage points to 4.74% compared to the previous year[57]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements made in the report[7]. - The company has detailed potential risks in the management discussion and analysis section of the report[9]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders or related parties[8]. - The company has not violated decision-making procedures for external guarantees[8]. - The company is facing risks from global trade protectionism, which may lead to reduced export orders and increased costs due to geopolitical tensions[105]. - The company is addressing global supply chain restructuring risks by enhancing customer relationships and improving supply chain resilience[107]. - The company is managing foreign exchange risk through financial instruments and optimizing settlement methods to mitigate the impact of currency fluctuations[108]. Strategic Initiatives - The company aims to enhance its core competitiveness through internationalization and high-quality development strategies[33]. - The company is focusing on optimizing its supply chain management in the textile and apparel sector, particularly in the export of knitwear products[48]. - The company is actively expanding its import and domestic trade business, leveraging opportunities from the China International Import Expo to enhance trade cooperation with emerging markets like RCEP and the Belt and Road Initiative[96]. - The company plans to strengthen capital and asset operations by 2025 to support long-term stable development and enhance operational efficiency[104]. - The company is committed to leveraging both domestic and international markets to achieve sustainable development and high-quality growth[91]. - The company is considering strategic acquisitions to enhance its market position, with a budget of $100 million allocated for potential deals[121]. Research and Development - Research and development expenses surged by 98.31%, reaching 159.71 million RMB, reflecting the company's commitment to innovation[52]. - The company’s R&D expenditure accounted for 0.05% of total operating revenue[63]. - The company is investing $50 million in R&D for new technologies aimed at enhancing product efficiency[121]. - Ongoing research and development efforts are expected to yield new innovations that align with market needs and consumer preferences[120]. Corporate Governance - The company held 12 board meetings during the reporting period, addressing key issues such as risk assessments and profit distribution plans[114]. - The company has established specialized committees, including an Audit Committee and a Compensation and Assessment Committee, to enhance governance[136]. - The company has updated its independent director management measures in line with new regulations[113]. - The company has confirmed that all equity contributions by the controlling shareholder have been made in full and on time, with no legal disputes or encumbrances on the equity held[171]. Market Trends - The global trade value of China's goods trade reached 43.85 trillion yuan in 2024, reflecting a year-on-year growth of 5%[35]. - The textile and apparel export trade is expected to face challenges due to ongoing trade protectionism and geopolitical conflicts, impacting the overall market dynamics[82]. - The overall market for textile and apparel exports is expected to remain under pressure, with potential impacts on the company's strategic goals for scale and structure optimization[82]. - The medical device import market in China has seen a decline in import value by 9.1%, 0.8%, and 4.7% in 2022, 2023, and 2024 respectively, due to domestic policies and market conditions[88]. Environmental and Social Responsibility - The company has implemented carbon reduction measures, including the development of energy-saving and environmentally friendly products[164]. - The company has committed to reducing carbon emissions through various initiatives, such as promoting green office practices and optimizing logistics systems[164]. - The company has successfully removed and repaired dangerous houses, improving the surrounding environment through its poverty alleviation projects[166]. - The company invested 130,000 yuan in poverty alleviation and rural revitalization projects during the reporting period[166]. Legal and Compliance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties during the reporting period[173]. - There are no significant legal disputes or guarantees that could affect the company's financial position[171]. - The company is currently involved in a lawsuit against Zhonggu Storage (Zhoushan) Co., Ltd. regarding the return of over 30,000 tons of light cycle oil, with the case being transferred to Ningbo Maritime Court[177].

东方国际创业股份有限公司 独立董事年度述职报告 陈子雷 我作为东方国际创业股份有限公司（以下简称"公司"）的独立董事，在任 职期间严格按照《公司法》、《上市公司独立董事管理办法》、《上市公司治理准则》 等法律、法规、规范性文件以及《公司章程》、《公司独立董事制度》的规定履行 职责。现将2024年度履行独立董事职责的情况报告如下： 一、独立董事的基本情况 陈子雷先生 出生于1966年12月，经济学博士、教授。曾任东京国际大学国 际交流研究所研究员，上海国际问题研究院助理研究员。现任上海对外经贸大学 日本经济研究中心主任、教授，三井住友海上火灾保险（中国）有限公司独立董 事、瑞穗银行（中国）有限公司独立董事、中国民主促进会上海市委员会市委委 员、上海市欧美同学会上海对外经贸大学分会会长、海南省发改委沪琼合作专家 顾问、全国日本经济学会副会长、上海市日本学会会长、上海市经济学会副秘书 长、上海市社联委员及公司第九届董事会独立董事。 2024年度，本人担任公司董事会薪酬与考核委员会召集人和战略委员会、审 计委员会委员。 二、独立董事年度履职概况 （一）2024年度本人出席董事会、董事会薪酬与考核委员会、董事会战略委 ...

东方创业（600278）公告，2024年营业收入354.29亿元，同比增长5.30%。归属于上市公司股东的净利 润2.16亿元，同比下降20.53%。向全体股东每股派发现金红利0.074元(含税)。 ...

证券代码：600278 证券简称：东方创业 公告编号：2025-013 东方国际创业股份有限公司 股权激励限制性股票回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购注销原因：公司2021年《A股限制性股票激励计划》（以下简称 "本激励计划"或"《激励计划》"）现有的284名激励对象中，有37名激励对象存 在与公司终止或解除劳动合同、绩效考核未完全达标、经董事会认定并确定需要回 购注销及业绩考核目标未完成等情况，公司将以上37名激励对象已获授但尚未解除 限售的限制性股票合计626,828股进行回购注销（以下简称"本次回购注销"），占 公司回购前总股本的0.0714%。 本次注销股份的有关情况： | 回购股份数量（股） | 注销股份数量（股） | 注销日期 | | --- | --- | --- | | 626,828 | 626,828 | 2025年4月24日 | 二、本次限制性股票回购注销情况 一、本次限制性股票回购注销的决策程序和信息披露情况 东方国际创业股份有限公司（以下简称"公司" ...

特此函告 你公司《关于股票交易异常波动的征询函》已收悉。经自查,现就所征询事 项回复如下: 1、我司目前生产经营情况正常,未发生不存在影响你司股票交易价格异常 波动的重大事宜。 2、我司不存在其他应披露而未披露的重大信息,包括但不限于筹划涉及上 市公司的重大资产重组、股份发行、重大交易类事项、业务重组、股份回购、股 权激励、破产重整、重大业务合作、引进战略投资者等重大事项。 东方国际创业股份有限公司: ...

证券代码：600278 证券简称：东方创业 编号：临 2025-012 东方国际创业股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●东方国际创业股份有限公司（以下简称"本公司"或"公司"）股票（股票简 称：东方创业，股票代码：600278）连续三个交易日涨幅偏离值累计超过 20%，属于 股票交易异常波动情形。 一、 股票交易异常波动的具体情况 2025 年 4 月 9 日、4 月 10 日、4 月 11 日，公司股票交易连续三个交易日涨幅 偏离值累计超过 20%，根据《上海证券交易所交易规则》的有关规定，属于股票交易 异常波动。 二、 公司关注并核实的相关情况 （一）生产经营情况 经公司自查，公司目前生产经营正常。公司主营外贸进出口业务 2025 年度经营 业绩存在一定的不确定性。公司生产成本和销售等情况未出现大幅波动、内部生产 经营秩序正常、近期未签订或磋商重大合同、上市公司主业经营未涉及新技术、新 产业、新业态、新模式等。 （二）重大事项情况 ●2024 年 1-9 月 ...

东方创业：目前生产经营正常，公司生产成本和销售等情况未出现大幅波动 金十数据4月11日讯，东方创业4月11日发布公告，2025年4月9日、4月10日、4月11日，公司股票交易连 续三个交易日涨幅偏离值累计超过20%，根据《上海证券交易所交易规则》的有关规定，属于股票交易 异常波动情形。经核实，公司目前生产经营正常。公司主营外贸进出口业务2025年度经营业绩存在一定 的不确定性。公司生产成本和销售等情况未出现大幅波动、内部生产经营秩序正常、近期未签订或磋商 重大合同、上市公司主业经营未涉及新技术、新产业、新业态、新模式等。 ...

东方创业：公司主营的外贸进出口业务2025年度经营业绩存在一定的不确定性 智通财经4月11日电，东方创业(600278.SH)公告称，公司股票连续三个交易日涨幅偏离值累计超过 20%，属于股票交易异常波动情形。公司目前生产经营正常，但主营的外贸进出口业务2025年度经营业 绩存在一定的不确定性。经自查和函证，公司不存在应披露而未披露的重大信息，公司董事、监事、高 级管理人员、控股股东及其一致行动人在股票交易波动期间没有买卖公司股票。 ...

A股贸易板块走高，远大控股、东方创业涨停，怡亚通、江苏国泰、汇鸿集团、凯瑞德、中成股份等跟 涨。 ...

贸易板块走高，远大控股（000626）、东方创业（600278）涨停，怡亚通（002183）、江苏国泰 （002091）、汇鸿集团（600981）、凯瑞德（002072）、中成股份（000151）等跟涨。 暗盘资金正涌入这些股票，点击速看>>> ...